The news is directly about Sabra Health Care REIT and is likely to influence investor sentiment. The Hold rating suggests that the analyst believes the stock is fairly valued at current levels, while the price target of $13 provides a reference point for investors. However, as this is just one analyst's opinion, the impact on the stock's price in the short term may be limited.